Evidence map›Paper›PMID 27676442›Full record

ArticleTranslational psychiatry2016

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.

M S Alexander, M J Gasperini, P T Tsai, D E Gibbs, J M Spinazzola, J L Marshall, M J Feyder, M T Pletcher, E L P Chekler, C A Morris and 5 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Evolution of CTCF binding sites in the human genome.Molecular biology and evolution · 2026
    Article
  2. Article
  3. Review
  4. The behavioural consequences of dystrophinopathy.Disease models & mechanisms · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Current Perspectives in Autism Spectrum Disorder: From Genes to Therapy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

M S AlexanderDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
M J GasperiniDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
P T TsaiThe F.M. Kirby Neurobiology Center, Translational Neuroscience Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
D E GibbsDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
J M SpinazzolaDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
J L MarshallDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
M J FeyderDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
M T PletcherRare Disease Research Unit, Pfizer, Cambridge, MA, USA.
E L P CheklerRare Disease Research Unit, Pfizer, Cambridge, MA, USA.
C A MorrisRare Disease Research Unit, Pfizer, Cambridge, MA, USA.
M SahinThe F.M. Kirby Neurobiology Center, Translational Neuroscience Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
J F HarmsNeuroscience Research Unit, Pfizer Global Research and Development, Cambridge, MA, USA.
C J SchmidtNeuroscience Research Unit, Pfizer Global Research and Development, Cambridge, MA, USA.
R J KleimanThe F.M. Kirby Neurobiology Center, Translational Neuroscience Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
L M KunkelDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
Boston Children's Hospital · USPfizer (United States) · USHarvard University · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Modulation of Jagged1/Pitpna in DMD as a means of therapyR01AR064300 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI KUNKEL, LOUIS M · 2014 to 2023
$3.9M
Mechanisms underlying the Cerebellar Contribution to Autism in Mouse Models of Tuberous Sclerosis ComplexK08NS083733 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI TSAI, PETER T. · 2013 to 2017
$952k
NIAMS NIH HHS R01 AR064300NICHD NIH HHS P30 HD018655NICHD NIH HHS U54 HD090255NINDS NIH HHS K08 NS083733
6 · The paper itself

Abstract

Duchenne muscular dystrophy is caused by mutations in the DYSTROPHIN gene. Although primarily associated with muscle wasting, a significant portion of patients (approximately 25%) are also diagnosed with autism spectrum disorder. We describe social behavioral deficits in dystrophin-deficient mice and present evidence of cerebellar deficits in cGMP production. We demonstrate therapeutic potential for selective inhibitors of the cGMP-specific PDE5A and PDE9A enzymes to restore social behaviors in dystrophin-deficient mice.

Identifiers

PMID27676442
PMCPMC5048211
OpenAlexW2524182942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.